GoodRx (GDRX) vs SOPHiA GENETICS SA (SOPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SOPHiA GENETICS SA (SOPH) has outperformed GoodRx (GDRX) over the past year, gaining 62.9% versus a loss of 23.5%. Over five years, SOPH leads with a -54.7% price change compared with -92.1% for GDRX. GoodRx is the larger company by market cap ($1.17 billion vs $630.8 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GDRX | SOPH |
|---|---|---|
| Share price | $3.43 | $7.41 |
| Market cap | $1.17B | $630.80M |
| 1-day change | +2.08% | +1.51% |
| YTD return | +23.99% | +56.32% |
| 1-year return | -23.46% | +62.95% |
| 5-year return | -92.08% | -54.66% |
| P/E ratio (TTM) | 68.60 | — |
| Forward P/E | 9.67 | — |
| EPS (TTM) | $0.05 | $-1.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.72 | $8.98 |
| 52-week low | $1.77 | $3.75 |
| Distance from 52-week high | -27.33% | -17.48% |
| Analyst consensus | hold | none |
| Avg. price target upside | +15.16% | +31.58% |
| Average volume | 1.27M | 549.78K |
| Shares outstanding | 107.18M | 85.13M |
| Employees | 697 | 415 |
| Sector | Technology | Technology |
| Industry | EDP Services | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SOPH has outperformed GDRX by 86.4 percentage points over the past year.
About GoodRx
GDRX stock →GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
Technology · EDP Services · 697 employees
About SOPHiA GENETICS SA
SOPH stock →SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Technology · EDP Services · 415 employees
GDRX vs SOPH FAQ
Which is bigger, GoodRx or SOPHiA GENETICS SA?
GoodRx (GDRX) is larger, with a market capitalization of $1.17B compared with $630.80M for SOPHiA GENETICS SA (SOPH).
Which stock has performed better over the past year, GDRX or SOPH?
SOPH returned +62.95% over the past 12 months, compared with -23.46% for GDRX (price return, excluding dividends). Past performance does not predict future results.
Are GoodRx and SOPHiA GENETICS SA in the same industry?
Yes. Both are classified in the EDP Services industry within the Technology sector.